Cargando…
A rare case of concurrent signet-ring carcinoma of breast and microangiopathic hemolytic anemia(†)
Microangiopathic hemolytic anemia (MAHA) can be an uncommon presentation of an underlying malignancy, most often due to signet-ring cell carcinoma (SRCC). Additionally, pure SRCC in a breast primary-tumor comprises <2% of all breast cancers (Shin SY, Park H, Chae SW, Woo HY. Microangiopathic hemo...
Autores principales: | Lara, Kelly, Bae, Esther, Park, Hanna, Hussain, Farabi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007612/ https://www.ncbi.nlm.nih.gov/pubmed/27587305 http://dx.doi.org/10.1093/jscr/rjw132 |
Ejemplares similares
-
Hemolytic Anemia of Malignancy: A Case Study Involving Signet Ring Cell Metastatic Breast Cancer with Severe Microangiopathic Hemolytic Anemia
por: Lee, Eric H., et al.
Publicado: (2019) -
About Microangiopathic Hemolytic Anemia
por: Özsoylu, Şinasi
Publicado: (2015) -
Microangiopathic Hemolytic Anemia as the First Manifestation of Metastatic Signet Ring Cell Carcinoma of Unknown Origin: A Case Report and Review of Literature
por: Shin, Sang-Yong, et al.
Publicado: (2011) -
Microangiopathic Hemolytic Anemia Is a Late and Fatal Complication of Gastric Signet Ring Cell Carcinoma: A Systematic Review and Case-Control Study
por: Lam, Robert, et al.
Publicado: (2022) -
Thrombotic Microangiopathic Hemolytic Anemia without Evidence of Hemolytic Uremic Syndrome
por: Özsoylu, Şinasi
Publicado: (2016)